MEIS2 and breast cancer: To further define the role of MEIS2 in BC development, we established control and MEIS2 stable knockdown (MEIS2‐KD) BC cells by transfecting MDA‐MB‐231 and T47D cells with lentiviruses engineered expressing MEIS2 or control shRNA, and selected by puromycin treatment.